Effect of JAK1/2 inhibition on High-Output Heart Failure Associated With Myeloproliferative Disease

There are reports of some patients with myeloproliferative disease (MPD) developing high-output heart failure (HOHF) ([1][1]). Another hematological disorder, multiple myeloma, is also known to be related to HOHF ([2][2]). According to the common pathological conditions in these 2 hematologic